In the spirit of ‘where are they now’ day comes another in my trilogy of companies I used to write about a lot, that I stopped writing about as…
Pharmaceuticals
Biotech flailer Hemostemix (HEM.V) took a punch to its distended gut today as a sell-off of the embattled stock cut the share price of the company by nearly half,…
Telesta (TST.T) will cease to exist should shareholders agree to an all-share deal offered by Prometic Life Sciences (PLI.T) for the company’s Belleville, Ontario vaccine production facility. That facility,…
Timeline: Mid 2015 – Laguna Blends (LAG.C) says, we’re coming. CEO lends company money. Market yawns. Late 2015 – Laguna Blends says, Naturally Splendid (NSP.V) is preparing our formula,…
Things you don’t want to see from your speculative drug research company stock: [Bellus Health] (BLU.T), a drug development company focused on rare diseases, today announced top-line results from…
When I was running the editorial show at Stockhouse, I had reason to look over a lot of messageboards for a wide variety of public companies. Almost without fail,…
Lots of weedness to discuss today folks, so let’s start with the most confusing of the lot. Golden Leaf Holdings (GLH.C) is a company I bailed on recently, selling…
Busy next few days as I’m going to ground to ferret out some new stories. As is tradition, I like to tell you ahead of time who I’m chatting…
Last December, Canadian Liberal Party mover/shaker, founding partner in Canopy Growth Corporation (CGC.V) and private equity player Chuck Rifici bought Wikileafs, the best named dispensary price comparison app out…
The only thing I knew about Zomedica (ZOM.V) prior to their launch on the TSX Venture Exchange Tuesday was 1) former Stockhouse eastern sales goddess Stephanie Mann is now…